Stay updated on Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.

Latest updates to the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page
- Check7 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5. This indicates a new release of the page version without altering the study content or history data.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.5.4 has been added and Revision: v3.5.3 has been removed. This updates the page's revision history to reflect the latest version rather than altering trial data or public content.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page’s interface revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a site/version update rather than any change to the underlying trial record.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check92 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed from the study record history.SummaryDifference0.1%

Stay in the know with updates to Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.